INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
GC

Gassert Chad

SVP - CORP. DEV. & STRATEGYCIK 0001871002

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 2
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
GC
Gassert ChadSVP - CORP. DEV. & STRATEGY
ANIPANI PHARMACEUTICALS INC
Tax withholding
F$326K
4,269 sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ANI PHARMACEUTICALS INCSVP - CORP. DEV. & STRATEGY · Nov 14, 2025
39
GC
Gassert ChadSVP - CORP. DEV. & STRATEGY
ANIPANI PHARMACEUTICALS INC
Open-market sale
SELL
$1.30M
14.6K sh
Nov 12, 2025
Nov 14, 2025
traded Nov 12, 2025
+2d
SEC FORM 4

Evidence

22
GC
Gassert ChadSVP - CORP. DEV. & STRATEGY
ANIPANI PHARMACEUTICALS INC
Open-market sale
SELL$8,272
94 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC FORM 4

Evidence